Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells

Yu Li,Houxi Xu,Danhong Cai,Sirui Zhu,Xiaoli Liu,Ye Zhao,Zhaofeng Zhang,Yaoyao Bian,Mei Xue,Liang Zhang
DOI: https://doi.org/10.1016/j.tiv.2020.105054
IF: 3.685
2021-02-01
Toxicology in Vitro
Abstract:<p>Overexposure to aristolochic acid I (AAI) can induce aristolochic acid nephropathy (AAN). However, the comprehensive mechanisms of AAI-induced nephrotoxicity have not been entirely explicated. To investigate the toxicological mechanisms by which AAI induces renal injury, human kidney cells (HK-2 cells) were subjected to comprehensive transcriptomic, proteomic and metabolomic analyses. The transcriptomic analysis identified a total of 7749 differentially expressed genes (DEGs) after AAI treatment, while the proteomic analysis found 598 differentially expressed proteins (DEPs) after AAI treatment. The metabolomic analysis revealed 49 and 42 differentially expressed metabolites (DEMs) in the positive and negative ion modes, respectively.</p><p>Gene Ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed on these DEGs, DEPs and DEMs. The results of the comprehensive analyses of transcripts, proteins, and metabolites indicated that the DEGs, DEPs, and DEMs were jointly regulated in three ways. These genes, proteins and metabolites and their related dysregulated pathways may be promising targets for research on the mechanisms of AAI injury in human renal epithelial cells. This study provides large-scale omics data that can be used to formulate new strategies for the prevention, rapid diagnosis, and treatment of AAI injury.</p>
toxicology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to distinguish unilateral breast edema caused by congestive heart failure (CHF) from inflammatory breast cancer (IBC) in clinical diagnosis. Since there are similarities in their clinical manifestations, especially when breast edema occurs unilaterally, this poses a diagnostic challenge for doctors. Through a specific case report and literature review, the paper shows that CHF may be a rare but need - to - consider cause of unilateral breast edema, especially in patients with a CHF background. The author emphasizes the importance of correct diagnosis for avoiding unnecessary examinations, treatments, and reducing medical costs and patient suffering. The case in the paper describes a 69 - year - old female patient who was admitted to the hospital due to symptoms such as dyspnea and had a history of long - term pulmonary hypertension, multiple hospitalizations for shortness of breath, chronic pericardial effusion, bronchial asthma, and leg edema. At admission, in addition to the above symptoms, the right breast was found to be enlarged, the skin showed an orange - peel - like change, and pitting edema was present. These symptoms were initially suspected to be inflammatory breast cancer. However, imaging examinations showed no obvious tumors but presented a breast edema pattern. After standard heart failure treatment, the patient's breast condition improved significantly. This case indicates that in some cases, CHF may be a potential cause of unilateral breast edema, not just limited to bilateral symptoms. Therefore, for patients with a CHF history, if unilateral breast edema occurs, the possibility of CHF should be considered and corresponding treatment observations should be carried out.